CRISPR Therapeutics Aktie
39,80
EUR
±0,00
EUR
±0,00
%
41,23
USD
+0,97
USD
+2,41
%
Werbung
CRISPR Therapeutics Aktie Analyse
26.07.19 | CRISPR Therapeutics Buy | Canaccord Adams | |
30.11.18 | CRISPR Therapeutics Buy | Needham & Company, LLC | |
15.05.18 | CRISPR Therapeutics Buy | Chardan Capital Markets | |
28.03.17 | CRISPR Therapeutics Buy | Chardan Capital Markets | |
14.11.16 | CRISPR Therapeutics overweight | Barclays Capital |
Werbung